Delivery Order SPE2DB20D2014-SPE2DB24FD18A

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,201.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a period of performance through January 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for...
This is a $1,385.37 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of HUMIRA PEN 40 MG/0.8 MLS. The award has an ultimate completion date of July 31, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a wide range of pharmaceutical products and medical supplies...
This $17,182.22 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical commodities to...
The U.S. Defense Logistics Agency (DLA) awarded a $5,344.82 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,058,929 units of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical...
This is a $5,554.60 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a period of performance through May 22, 2025. The contract is not set aside and was awarded as an open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a $4,154.61 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of HUMIRA(CF) PEN 80 MG/0.8 MLS, a pharmaceutical product, with a period of performance through June 18, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The fixed-price delivery order, valued at $5,541.48, was issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC, worth up to $999,999,999, enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment...
This is a $1,847.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA PEN 40 MG/0.8 MLS. The order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
This is a $2,770.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication, and is part of a larger $999,999,999 Indefinite Delivery Contract the company holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery...
This is a $17,776.15 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of September 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a range of medical commodities to support military...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD18A
    Delivery Order

This is a $5,541.48 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The order is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order has a period of performance through September 30, 2024. The contract is not set-aside and was awarded on September 27, 2024.

Generated 12/27/24, 9:20 AM